Impact of the economic sanctions on duodenal ulcer in Iraq
AbstractCases of duodenal ulcer admitted to Basra General Hospital for a one-year period prior to economic sanctions were compared with cases admitted in a one-year period during sanctions. The number of patients, age ranges, risk factors, complications, diagnosis, treatment and mortality rates were compared. The number of cases more than doubled during the period of sanctions. There was a significant increase in smoking among duodenal ulcer patients during sanctions. Other differences between the two periods were observed and reasons for these differences are discussed
Al Jawher, Mohamed H. (1997). Impact of the economic sanctions on duodenal ulcer in Iraq. EMHJ - Eastern Mediterranean Health Journal, 3 (3), 420-424, 1997 http://www.who.int/iris/handle/10665/117473
JournalEMHJ - Eastern Mediterranean Health Journal, 3 (3), 420-424, 1997
MetadataShow full item record
Showing items related by title and MeSH subject.
Ahmed, W.; Qureshi, H.; Zuberi, S.J.; Alam, S.E. (1998)A study was conducted to test the response to therapy and the relapse rates of endoscopically-confirmed duodenal ulcers. Endoscopy to check for healing was performed at 4 and 8 weeks in cases receiving H2-blockers and misoprostol and at 14 and 28 days in cases receiving a proton pump inhibitor. Endoscopy was repeated at 1, 3, 6 and 12 months to check for relapses. Healing rates were 61%-77% and 75%-85% at 4 and 8 weeks in the group receiving H2-blockers and misoprostol. Healing rates were 68% and 100% at days 14 and 28 with the proton pump ...
Zangana, A.M. (2007)The frequency of bleeding duodenal ulcer was assessed in patients admitted with upper gastrointestinal bleeding to Erbil City hospital from the Emergency Department during 1996-2004. Of 740 such patients, 556 [75.1%] were diagnosed with bleeding duodenal ulcer: 312 [56.1%] were managed conservatively while 238 [42.8%] underwent surgery. Overall mortality over the 9 years was 4.7%. Over the 3 consecutive 3-year periods, mortality fell from 7.1% in the first 3 years to 2.2% in the final 3 years. Overall mortality among the 238 patients treated ...